Resonetics completes acquisition of Resolution Medical

Resonetics has completed its acquisition of Resolution Medical, a move aimed at expanding the company's ability to provide integrated device solutions for interventional, structural heart and neuromodulation markets, the company announced.

The acquisition broadens Resonetics' capabilities in design, finished devices and sub-assembly work, enabling the company to support customers across the full product lifecycle from early development through commercialization and scaled production.

Resolution Medical brings biosimulation, design, new product introduction and cleanroom assembly expertise that will be integrated with Resonetics' existing precision component manufacturing, advanced materials and battery technologies. The combination is intended to help original equipment manufacturers reduce complexity and accelerate time to market.

"As device complexity increases, our customers are looking for partners who can take greater ownership across development and manufacturing," said Kevin Kelly, CEO of Resonetics. "Bringing Resolution Medical into the Resonetics platform strengthens our ability to execute integrated programs at scale and support the next generation of innovative therapies."

The acquisition is expected to particularly benefit customers in neuromodulation, where coordination across device design, electronics, batteries and assembly is critical.

Peter Herman, CEO of Resolution Medical, said joining Resonetics will allow the company to leverage broader manufacturing capabilities and global resources while maintaining its focus on solving complex engineering challenges.

The deal follows recent investments by Resonetics in battery, lead and implantable and external pulse generator manufacturing. Financial terms of the acquisition were not disclosed.